# Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

> **NCT00163267** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 80 (actual)

## Conditions studied

- Peripheral Vascular Diseases

## Interventions

- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT00163267
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2011-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163267, "Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00163267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*